Pramodini Medicare Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Pramodini Medicare Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.
Price Band
₹118
Per ShareLot Size
1200 Shares
Minimum Investment
₹1,41,600
Issue Size
₹69.04 Cr
Face Value
₹10
Per ShareIPO Type
Book Building - SME
Retail Quota
36.68%
QIB Quota
45.91%
NII Quota
17.41%
IPO Timeline
Important dates for your applying strategy.
Subscription Status
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Pramodini Medicare Ltd
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
85.71%
Promoter Holding (Post-Issue)
62.64%
Issue Type
Book Building - SME
ISIN
INE2JG601017
About the Company
We are a diagnostic service provider in India. We provide a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. Our diagnostic services include a comprehensive range of offerings: (i) "Radiology" which covers Magnetic Resonance Imaging (MRI), Computed Tomography (CT scan), X- ray, Ultrasound with colour doppler, Mammography, Dexa Scan and Intervention Radiology, (ii) "Clinical Laboratory" which includes Haematology, Micro-Biology, Immunology, Pathology & Bio-Chemistry and (iii) "Nuclear Medicine" which includes PET-CT (Positron Emission Tomography-Computed Tomography), SPECT (Single Photon Emission Computed Tomography) and Nuclear therapy. We also provide teleradiology services through our registered office situated at Vijayawada which functions on a 24x7 basis throughout the year. We provide healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Our services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
Company History
Our Company was originally incorporated on September 12, 2000 under the name "Pramodini Medicare Private Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Andhra Pradesh, Hyderabad. Thereafter, the status of our Company was changed to public limited Company and the name of our Company was changed to "Pramodini Medicare Limited" vide Special Resolution passed by the Shareholders at the Extra Ordinary General Meeting of our Company held on October 30, 2025. The fresh certificate of incorporation consequent to conversion was issued on November 12, 2025 by the Centralised Processing Centre. The Corporate Identification Number of our Company is U85110AP2000PLC035231.
Growth Strategy
- Expanding geographic footprint across the India.
- Increase in capacities at our existing diagnostic facilities.
- Expand our business and geographical footprint through opportunistic acquisitions.
- Continue to improve profitability and efficiency.
- Enhancing our brand image.
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial public offer of 58,51,200 equity shares of face value of Rs. 10/- each (the "Equity Shares") of Pramodini Medicare Limited ("The Company" or "Pramodini" or "The Issuer") at an offer price of Rs. 118 per equity share for cash, aggregating to Rs. 69.04 Crores comprising of fresh offer of 53,50,800 equity shares aggregating to Rs. 63.14 Crores ("Fresh Issue") and an offer for sale of 5,00,400 equity shares by Chalasani Kuldeep Kumar, Chalasani Kavitha and Sri Ram Medicare Private Limited ("Promoter Selling Shareholders") aggregating to Rs. 5.90 Crores ("Offer For Sale") ("Public Offer"). The offer includes a reservation of 3,36,000 equity shares of face value of Rs. 10/- each, at an offer price of Rs. 118 per equity share for cash, aggregating Rs. 3.96 Crores will be reserved for subscription by the market maker to the offer (the "Market Maker Reservation Portion"). The public offer less market maker reservation portion i.e. Net offer of 55,15,200 equity shares of face value of Rs.10/-each, at an offer price of Rs. 118 per equity share for cash, aggregating Rs. 65.08 Crores is herein after referred to as the "Net Offer". The public offer and net offer will constitute 26.54% and 25.02% respectively of the post- offer paid-up equity share capital of the company. Price Band: Rs. 118/- per equity share of face value of Rs. 10/- each. The floor price is 11.80 times of the face value of the equity shares. Bids can be made for a minimum of 1,200 equity shares and in multiples of 1,200 equity shares thereafter.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Establishing a Strategic presence across various states of India.
- Strengthening Our Network with Diversified Models.
- Technical Capability with robust IT Infrastructure.
- Dedicated Management Team with Significant Industry Experience.
- Track record of revenue and financial performance.
- A significant portion of the company's revenue from operations is derived from MOUs with government authorities under Public Private Partnership (PPP) arrangements. Any non-renewal, modification, or termination of such MOUs, or delays or failures in realizing payments from government authorities, may materially and adversely affect its business, financial condition and results of operations.
- Concentrated emphasis on radiology services also exposes it to substantial risks that could adversely impact the company's operations, financial performance, and long-term growth prospects.
- The company derives substantial portion of its revenue from the state of Andhra Pradesh and any loss of business in such regions could have an adverse effect on the company's business, results of operations and financial condition.
- The company is majorly dependent on certain key customers cum patients for a substantial portion of its revenues. Loss of relationship with any of these customers cum patients may have a material adverse effect on the company's profitability and results of operations.
- The company derives a significant portion of its revenue from government authorities (B2G). Any reduction in revenue from them or delays in payments by government authorities, may adversely affect the company's business, financial condition and results of operations.